

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb289</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>&lt;i&gt;Lactococcus lactis&lt;/i&gt;: A New Strategy for Vaccination</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Azizpour</surname><given-names>Maryam</given-names></name></contrib><aff>Laboratory of System Biology and Bioinformatics (LBB), Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Hosseini</surname><given-names>Seyyed Davood</given-names></name></contrib><aff>Department of Animal Science, Research Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Jafari</surname><given-names>Parvaneh</given-names></name></contrib><aff>Bioinformatics and Computational Omics. LAB (BioCOOL), Faculty of Biological Sciences, Tarbiat Modares University (TMU), Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Akbary</surname><given-names>Neda</given-names></name></contrib><aff>Department of Food Hygiene and Public Health, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>9</volume>
      <issue>4</issue>
      <fpage>163</fpage>
      <lpage>168</lpage>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>6</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>12</month>
          <year>2016</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Needle free vaccines have a several advantages and very attractive way for vaccination. In a body, mucosal surfaces provide a universal entry portal for all the known and emerging infectious pathogenic microbes. Therefore, it seems, vaccination strategies need to be reorganized for vaccines that are hindering the entry capability of pathogenic microbes through mucosal surfaces. Lactic acid Bacteria (LAB) are widely used in the food industry and at the present, used as delivery vehicles for biological investigations. In this review, we summarized the Results of several studies which &lt;em&gt;Lac-tococcus lactis (L. lactis)&lt;/em&gt; used as a live vector for vaccines. These bacteria are considered as promising candidates for heterologous expression of proteins and biotechnological usage. LAB are considered as promising candidates for heterologous expression of proteins and biotechnological usage. The results showed that these bacteria have an ability to deliver antigen to immune system. Therefore, developing mucosal live vaccines using lactic acid bacterium,&lt;em&gt; L. lactis&lt;/em&gt;, as an antigen delivery vector, is an attractive alternative choice and a safer vaccination strategy against pathogens.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
